Gonorrhoea strains across Europe becoming more susceptible to main treatment options

(European Centre for Disease Prevention and Control (ECDC)) According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010. However, resistance to one antibiotic agent which is part of the suggested dual therapy of gonorrhoea remains high and threatens the effectiveness of this regimen.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news